Nomura Research Institute... (NRILY)
OTC: NRILY
· Real-Time Price · USD
41.06
-0.23 (-0.57%)
At close: Aug 15, 2025, 12:23 PM
Nomura Research Institute Income Statement
Financials in JPY. Fiscal
year is
April - March.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 196.57B | 191.47B | 188.67B | 188.11B | 186.54B | 187.95B | 185.35B | 176.71B | 176.11B | 177B | 171.52B | 167.54B | 163.69B | 155.97B | 149.33B | 142.65B | 145.87B | 138.13B | 135.11B | 131.12B |
Cost of Revenue | 126.86B | 120.6B | 121.61B | 120.45B | 120.51B | 121.35B | 120.15B | 113.54B | 116.04B | 114.74B | 111.32B | 110.23B | 107.67B | 99.83B | 96.59B | 91.47B | 96.27B | 89.52B | 89.04B | 89.52B |
Gross Profit | 69.71B | 70.86B | 67.06B | 67.66B | 66.03B | 66.61B | 65.2B | 63.17B | 60.06B | 62.26B | 60.19B | 57.31B | 56.02B | 56.14B | 52.74B | 51.18B | 49.6B | 48.61B | 46.07B | 41.59B |
Operating Income | 32.55B | 36.72B | 30.53B | 32.64B | 29.02B | 30.41B | 31.4B | 27.83B | 27.18B | 28.15B | 27.15B | 25.77B | 24.93B | 27.83B | 27.33B | 23.28B | 17.6B | 24.12B | 22.02B | 17.85B |
Interest Income | n/a | n/a | n/a | 1.34B | 693M | 991M | 755M | 1.03B | 334M | 751M | 204M | 928M | 480M | 516M | 318M | 656M | 1.75B | 319M | 5M | 1.15B |
Pretax Income | 32.57B | 36.15B | 33.39B | 32.05B | 27.79B | 31.4B | 30.82B | 26.43B | 26.94B | 27.49B | 25.91B | 27.7B | 24.78B | 26.17B | 26.8B | 26.71B | 4.14B | 21.43B | 20.47B | 16.84B |
Net Income | 21.97B | 26.14B | 23.49B | 22.17B | 18.55B | 23.43B | 20.45B | 17.21B | 21.27B | 19.18B | 17.09B | 18.76B | 17.13B | 17.8B | 18.1B | 18.41B | 8.07B | 14.62B | 13.57B | 11.81B |
Selling & General & Admin | 37.57B | 34.95B | 35.08B | 36.47B | 35.4B | 34.85B | 32.34B | 34.46B | 31.72B | 32.86B | 31.55B | 30.54B | 29.72B | 27.19B | 24.06B | 26.75B | 25.32B | 24.71B | 24.13B | 23.74B |
Research & Development | n/a | n/a | n/a | n/a | 1.61B | 1.34B | 1.46B | 886M | 1.16B | 1.25B | 1.49B | 1B | 1.36B | 1.12B | 1.35B | 1.16B | 4.47B | n/a | n/a | n/a |
Other Expenses | -415M | -807M | 1.45B | -1.45B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 67M | 165M | -82M |
Operating Expenses | 37.16B | 34.15B | 36.53B | 35.02B | 37.01B | 36.2B | 33.8B | 35.34B | 32.88B | 34.11B | 33.05B | 31.54B | 31.08B | 28.31B | 25.41B | 27.9B | 32.06B | 24.58B | 24.1B | 23.67B |
Interest Expense | n/a | n/a | n/a | 1.93B | 1.91B | 1.63B | 1.63B | 1.48B | 1.24B | 1.67B | 1.43B | 1.22B | 507M | 1.64B | 887M | 483M | 11.21B | 3.01B | 1.56B | 2.15B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.61B | -1.34B | -1.46B | -886M | -1.16B | -1.25B | -1.49B | -1B | -1.38B | -1.73B | -1.35B | -1.36B | n/a | n/a | n/a | n/a |
Cost & Expenses | 164.01B | 154.75B | 158.14B | 155.47B | 157.52B | 157.54B | 153.96B | 148.88B | 148.93B | 148.85B | 144.37B | 141.77B | 138.75B | 128.15B | 122B | 119.37B | 128.33B | 114.1B | 113.13B | 113.19B |
Income Tax Expense | 10.39B | 9.88B | 9.79B | 9.72B | 9.23B | 8.18B | 10.37B | 9.29B | 5.83B | 8.49B | 8.74B | 8.94B | 7.62B | 8.44B | 8.55B | 8.27B | -3.33B | 6.58B | 6.54B | 5.61B |
Shares Outstanding (Basic) | 572.02M | 571.64M | 573.76M | 575.74M | 576.21M | 576.36M | 584.31M | 590.34M | 594.25M | 592.19M | 591.28M | 589.96M | 589.3M | 588.82M | 589.77M | 602.37M | 601.81M | 598.76M | 598.07M | 596.52M |
Shares Outstanding (Diluted) | 572.02M | 571.63M | 573.76M | 575.7M | 576.25M | 576.63M | 584.64M | 590.72M | 594.25M | 592.71M | 592.01M | 590.79M | 590.33M | 590.02M | 590.93M | 604.37M | 601.81M | 600.34M | 599.6M | 598.11M |
EPS (Basic) | 38.40 | 45.73 | 40.94 | 38.50 | 32.23 | 40.65 | 35.00 | 29.29 | 35.80 | 32.38 | 28.91 | 31.80 | 29.07 | 30.23 | 30.91 | 30.56 | 13.45 | 24.42 | 22.70 | 19.80 |
EPS (Diluted) | 38.40 | 45.73 | 40.94 | 38.50 | 32.22 | 40.63 | 34.98 | 29.28 | 35.80 | 32.35 | 28.87 | 31.76 | 29.02 | 30.17 | 30.84 | 30.46 | 13.42 | 24.35 | 22.64 | 19.75 |
EBITDA | 44.71B | 48.4B | 45.03B | 44.77B | 40.42B | 44.35B | 43.73B | 38.6B | 37.53B | 39.94B | 37.98B | 39.22B | 32.3B | 37.86B | 37.63B | 36.81B | 37.26B | 34.73B | 32.37B | 29.07B |
EBIT | 32.41B | 36.29B | 32.81B | 32.49B | 29.86B | 33.36B | 32.59B | 28.06B | 28.29B | 29.36B | 27.39B | 29.01B | 25.33B | 27.98B | 27.67B | 27.22B | 15.35B | 24.44B | 22.03B | 19B |
Depreciation & Amortization | 12.3B | 12.12B | 12.21B | 12.28B | 12.1B | 12.31B | 12.03B | 11.72B | 11.48B | 11.54B | 10.84B | 11.23B | 10.85B | 10.57B | 10.26B | 10.27B | 17.5B | 10.29B | 10.34B | 10.07B |